Neurexan (Avena Sativa D2, Passiflora Incarnata D2, Zincum Isovalerianicum D4, Coffea Arabica D12)

The active ingredients—Avena Sativa, Passiflora Incarnata, Zincum Isovalerianicum and Coffea Arabica—are highly diluted extracts that are believed to modulate central nervous system pathways, potentially influencing GABA activity and stress‑related hormonal responses, which may promote a calming effect.

The dosing regimen for Neurexan is determined by the prescribing healthcare professional based on the individual’s condition, age and response. Patients should follow the specific instructions provided by their prescriber.

Safety data for Neurexan in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Neurexan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Neurexan is a homeopathic formulation, differing from conventional anxiolytics such as benzodiazepines or selective serotonin reuptake inhibitors, which have well‑defined pharmacologic actions. Neurexan is generally considered for mild symptoms and may have a more favorable side‑effect profile, but its efficacy is based on homeopathic principles rather than conventional drug mechanisms.

Neurexan tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

Neurexan is taken orally as a tablet. The tablet should be swallowed whole with water, unless otherwise directed by a healthcare professional. It is not intended for sublingual or intravenous administration.

Serious but rare risks include anaphylactic reactions, severe skin eruptions, hepatic dysfunction and respiratory distress. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, widespread rash, jaundice or persistent dizziness.

Individuals with known hypersensitivity to any of the listed ingredients, those taking strong CNS depressants without medical supervision, and patients with severe hepatic or renal impairment should avoid Neurexan unless advised otherwise by a qualified healthcare professional.